poster_listing by xiaopangnv

VIEWS: 10 PAGES: 44

									Poster Session Date      Assigned ID Title
Sunday, February 13th 1- C1-CC001    A Comparison of Sleep Quality in
2pm                                  Rheumatoid Arthritis and Osteoarthritis
                                       Patients




Sunday, February 13th 1- C1-CC002      Assessing the Rate of Serious Infections in
2pm                                    Rheumatoid Arthritis (RA) Patients who
                                       Receive Other Biologic Therapies after
                                       Discontinuing Rituximab (RTX)




Sunday, February 13th 1- C1-CC003      Safety Analysis of Tocilizumab (TCZ) in
2pm                                    Rheumatoid Arthritis (RA) Patients (pts): Long-
                                       Term Extension Studies (Median of 3.1 Years
                                       of Treatment)




Sunday, February 13th 1- C1-CC004      Low Rates of Infliximab Dose Titration and
2pm                                    Discontinuation Are Observed in
                                       Rheumatoid Arthritis (RA) Patients in a
                                       Real-life Canadian Cohort
Sunday, February 13th 1- C1-CC005      Long-term Safety, Under Routine Care, of
2pm                                    Infliximab in Patients With Rheumatoid
                                       Arthritis in a Large Canadian Cohort




Sunday, February 13th 1- C1-CC006      Profile of Patients with Rheumatoid
2pm                                    Arthritis Treated With Infliximab in Canada-
                                       Trends Toward Less DMARD Use Prior to
                                       a Biologic, Earlier Use of Infliximab and
                                       Differences in Baseline Disease<
Sunday, February 13th 1- C1-CC007   Treating Rheumatoid Arthritis to Target: A
2pm                                 Canadian Physician Survey




Sunday, February 13th 1- C1-CC008   Results from the RESET Study: Rituximab
2pm                                 Response Based on Reasons for TNFi-
                                    Discontinuation and Rheumatoid Factor
                                    Status

Sunday, February 13th 1- C1-CC009   Time to and Level of Initial DAS28 Change
2pm                                 With Certolizumab Pegol Predicts the
                                    Likelihood of Having Low Disease Activity at
                                    Years 1 and 2 in Patients With Rheumatoid
                                    Arthritis




Sunday, February 13th 1- C1-CC010   Comorbidity is Commonly Reported in Early
2pm                                 Inflammatory Arthritis




Sunday, February 13th 1- C1-CC011   Disease Activity in Patients Prescribed
2pm                                 Biologics in Ontario: Results from the OBRI




Sunday, February 13th 1- C1-CC012   Regional Variation of the Profile of Patients
2pm                                 With Rheumatoid Arthritis Treated With
                                    Infliximab in Quebec and Ontario
Sunday, February 13th 1- C1-CC013   Sex Differences in Pain Level and Location in
2pm                                 Inflammatory Arthritis: A Systematic Review
                                    and Meta-Analysis




Sunday, February 13th 1- C1-CC014   Patient Sex Does Not Influence Pain Levels in
2pm                                 Early Inflammatory Arthritis




Sunday, February 13th 1- C1-CC015   A Conceptual Framework for the Design of
2pm                                 Real-Time Systems for Clinical Monitoring
                                    and Research in Rheumatology




Sunday, February 13th 1- C1-CC016   Assessing the Efficacy of Early Optimal
2pm                                 Parenteral Methotrexate in an ERA Cohort,
                                    Single-site Experience


Sunday, February 13th 1- C1-CC017   Correlation of CDAI and SDAI with DAS in
2pm                                 a Large, Real-life Cohort of RA Patients
                                    Treated With Infliximab


Sunday, February 13th 1- C1-CC018   Unaffected First-Degree Relatives of RA
2pm                                 Patients Exhibit a High Prevalence of Joint
                                    Symptoms That Is Not Explained by the
                                    Presence of RA Autoantibodies: Studies in a
                                    Predisposed North American Native
Sunday, February 13th 1- C1-CC019   Efficacy and Safety of Certolizumab Pegol
2pm                                 Plus Methotrexate in Patients With
                                    Rheumatoid Arthritis: 3-Year Data From the
                                    RAPID 2 Study




Sunday, February 13th 1- C1-CC020   Efficacy Sustained After Dose De-escalation
2pm                                 of Certolizumab Pegol in Rheumatoid Arthritis
                                    Patients: Post-hoc Analysis of the RAPID 2
                                    Open-label Extension




Sunday, February 13th 1- C1-CC021   Number Needed to Treat to Achieve Broad
2pm                                 Relief From the Burden of Rheumatoid
                                    Arthritis (RA) in Patients Treated With
                                    Certolizumab Pegol Plus Methotrexate




Sunday, February 13th 1- C1-CC022   Long-Term Safety of Rituximab (RTX):
2pm                                 Rheumatoid Arthritis (RA) Clinical Trials and
                                    Retreatment Population




Sunday, February 13th 1- C1-CC023   The Role of the Patient Ambassador in
2pm                                 Support of the Identified Theme of Hope in
                                    the Needs of Patients Attending an
                                    Inflammatory Arthritis Education Program at
                                    The Arthritis Program (TAP).
Sunday, February 13th 1- C1-CC024   Does Age Influence Choice of
2pm                                 Pharmacotherapy for Rheumatoid Arthritis?

Sunday, February 13th 1- C1-CC025   Tocilizumab (TCZ) Long-Term Efficacy in
2pm                                 Rheumatoid Arthritis (RA) Patients (pts)
                                    Treated up to 3.7 Years




Sunday, February 13th 1- C1-CC026   Age Differences in the Prescription of
2pm                                 Biologics versus DMARDs




Sunday, February 13th 1- C1-CC027   Prevalence of and Predictive Factors for
2pm                                 Sustained Remission in Early RA: Results
                                    from SONORA Study


Sunday, February 13th 1- C1-CC028   Efficacy of Tocilizumab (TCZ) in Rheumatoid
2pm                                 Arthritis (RA) Patients (pts) with No Prior
                                    Exposure to or No Prior Failure of
                                    Methotrexate (MTX): Long-Term Extension
                                    Study (Up to 3 Years of Treatment)




Sunday, February 13th 1- C1-CC029   Experience with Accelerated Rituximab
2pm                                 Infusion for Rheumatoid Arthritis in a Single
                                    Community Practice
Sunday, February 13th 1- C1-CC030   Baseline Characteristics and Effectiveness of
2pm                                 Treatment With Infliximab in Canadian
                                    Patients With Rheumatoid Arthritis:
                                    Comparison of an Individual Practice With the
                                    BioTRAC Registry
Sunday, February 13th 1- C1-CC031   Incidence of Post-operative Complications
2pm                                 following Orthopaedic Procedures in Patients
                                    with Rheumatoid Arthritis treated with TNF-α
                                    Inhibitor Therapy
Sunday, February 13th 1- C1-CC032   Sleep Evaluation Before and After Initiation of
2pm                                 Anti-Tumour Necrosis Factor Therapy in
                                    Rheumatoid Arthritis




Sunday, February 13th 1- C1-CC033   The Relationship between Function and
2pm                                 Disease Activity as Measured by HAQ DI and
                                    DAS Varies by Rheumatoid Factor Status in
                                    ERA. Results from the CATCH cohort.




Sunday, February 13th 1- C1-CC034   Treatment to Target: Retreatment with
2pm                                 Rituximab (RTX) Provides Better Disease
                                    Control than Treatment as Needed in Patients
                                    with Rheumatoid Arthritis (RA)




Sunday, February 13th 1- C1-CC035   Exploring the Needs of People with
2pm                                 Rheumatoid Arthritis


Sunday, February 13th 1- C1-CC036   Safety of Infliximab Treatment in a Real-
2pm                                 World Clinical Setting: Description and
                                    Evaluation of Infusion Reactions




Sunday, February 13th 1- C1-CC037   A Description of Surgical Procedures Among
2pm                                 Patients with Rheumatoid Arthritis on
                                    Infliximab Treatment




Sunday, February 13th 1- C1-CC038   Development, Evaluation and Implementation
2pm                                 of a Successful Interprofessional Education
                                    Program for Adults with Inflammatory Arthritis
Sunday, February 13th 1- C1-CC039   Information Needs And Information-Seeking
2pm                                 By People With Rheumatoid Arthritis: A
                                    Qualitative Study




Sunday, February 13th 1- C1-CC040   Detecting Latent Tuberculosis Infection during
2pm                                 Anti-Tumour Necrosis Factor Therapy




Sunday, February 13th 1- C1-CC041   Clinical Trials in Canada – A Review of Study
2pm                                 Design and Selection Criteria in Rheumatoid
                                    Arthritis (RA) Trials




Sunday, February 13th 1- C1-CC042   Disconnect Between Disease Activity and
2pm                                 Joint Space Narrowing for Patients with Early
                                    Ra Treated with Adalimumab plus
                                    Methotrexate but not Methotrexate Alone:
                                    Case for Anti-Tnf Cartilage Protection




Sunday, February 13th 1- C1-CC043   Clinical and Radiographic Implications of
2pm                                 Time to Treatment Response in Patients With
                                    Early Rheumatoid Arthritis




Sunday, February 13th 1- C1-CC044   Psychometric Properties of Self-Administered
2pm                                 Early Inflammatory Arthritis Detection Tool
Sunday, February 13th 1- C1-CC045   Demyelinating events in Seniors with
2pm                                 Rheumatoid Arthritis (RA): A Population-
                                    based Study




Sunday, February 13th 1- C1-CC046   The Incidence of Herpes Zoster in Seniors
2pm                                 with Rheumatoid Arthritis: A Population-
                                    Based Study




Sunday, February 13th 1- C1-CC047   Primary anti-TNF Failures Experience Better
2pm                                 Clinical Responses but Similar Health Care
                                    Utilization to a Second anti-TNF Agent than
                                    Secondary Failures: Analysis of the Alberta
                                    Rheumatoid Arthritis Biologics Registry




Sunday, February 13th 1- C1-CC048   Management of Rheumatoid Arthritis in the
2pm                                 Peri-operative Period: A Look at the
                                    Literature and Local Practices

Sunday, February 13th 1- C1-CC049   Prevalence of Metabolic Syndrome in
2pm                                 Psoriasis and Psoriatic Arthritis




Sunday, February 13th 1- C1-CC050   Psoriatic arthritis (PsA) in Canadian Clinical
2pm                                 Practice: the PsA Assessment in
                                    Rheumatology (PAIR)
Sunday, February 13th 1- C1-CC051   Patient-physician discordance of global
2pm                                 disease assessment in psoriatic arthritis
                                    patients


Sunday, February 13th 1- C1-CC052   Seasonal Variation in Vitamin D Levels in
2pm                                 Patients with Psoriatic Arthritis from Northern
                                    and Southern Latitudes and its Association
                                    with Clinical Outcomes




Sunday, February 13th 1- C1-CC053   A Comparison of Methotrexate Use Amongst
2pm                                 Dermatologists and Rheumatologists in
                                    Canada
Sunday, February 13th 1- C1-CC055   Predictors of Radiographic Progression in
2pm                                 Adalimumab-Treated Patients with
                                    Ankylosing Spondylitis




Sunday, February 13th 1- C1-CC056   Scleroderma prevalence in Alberta: A
2pm                                 population-based assessment.




Sunday, February 13th 1- C1-CC057   Development and Validation of a Pruritus
2pm                                 Measure in Patients with Systemic Sclerosis




Sunday, February 13th 1- C1-CC058   Expert Agreement of EULAR / EUSTAR
2pm                                 Recommendations for the Management of
                                    Systemic Sclerosis
Sunday, February 13th 1- C1-CC059   Treatment of Vascular Involvement in
2pm                                 Systemic Sclerosis (SSc): What to use when
                                    first-line treatment fails - a consensus of SSc
                                    experts.
Sunday, February 13th 1- C1-CC060   Oral Health Related Quality of Life and
2pm                                 Clinical Features in Systemic Sclerosis




Sunday, February 13th 1- C1-CC061   Can Body Mass Index Be Considered a
2pm                                 Differentiating Factor when Diagnosing
                                    Systemic Sclerosis?

Sunday, February 13th 1- C1-CC062   The Relationship Between Oral Health and
2pm                                 Psychosocial Outcomes in Systemic
                                    Sclerosis




Sunday, February 13th 1- C1-CC063   The Efficacy of Non-biologic Disease-
2pm                                 modifying Antirheumatic Drugs (DMARDs) in
                                    the Treatment of Pain in Early Versus Late
                                    Inflammatory Joint Disease (IJD): a
                                    Systematic Literature Review




Sunday, February 13th 1- C1-CC064   Efficacy and Safety of Febuxostat and
2pm                                 Allopurinol in Women with Gout, An Older
                                    Subset With Increased Comorbidity




Sunday, February 13th 1- C1-CC065   Progression Patterns of Radiographic
2pm                                 Damage: Results from SONORA Study
Sunday, February 13th 1- C1-CC066   A Canadian Survey Regarding
2pm                                 Musculoskeletal Imaging for Rheumatology
                                    Residents




Sunday, February 13th 1- C1-CC067   Does Moderate or Severe Knee Strain Affect
2pm                                 the Progression of Radiographic
                                    Osteoarthritis?




Tuesday, February 15th C2-CC068     Postal Survey of Pregnancy in Rheumatoid
1-2pm                               Arthritis and Systemic Lupus Erythematosus
                                    Patients

Tuesday, February 15th C2-CC069     The Prevalence of Systemic Lupus in Alberta:
1-2pm                               A Population-based Assessment




Tuesday, February 15th C2-CC070     Adverse Obstetrical and Neonatal Outcomes
1-2pm                               in RA and SLE


Tuesday, February 15th C2-CC071     Which Coping Strategies do Women Living
1-2pm                               with Systemic Lupus Erythematosus Utilize?
Tuesday, February 15th C2-CC072   Examination of Steroid Dose and Steroid-
1-2pm                             related Damage in an International Inception
                                  Cohort of Systemic Lupus Erythematosus
                                  Patients


Tuesday, February 15th C2-CC073   Treatment of Hypertension and
1-2pm                             Hypercholesterolemia is not Successful in the
                                  Majority of Patients with Systemic Lupus
                                  Erythematosus

Tuesday, February 15th C2-CC074   Smoking Significantly Increases Disease
1-2pm                             Activity in Systemic Lupus Erythematosus
                                  (SLE): Results from the 1000 Faces of Lupus
                                  Cohort




Tuesday, February 15th C2-CC075   Clinical Significance Of Renal Vascular
1-2pm                             Lesions (RVL) On Renal Biopsy In Lupus
                                  Nephritis.
Tuesday, February 15th C2-CC076   Outcomes of SLE Patients Cared for by
1-2pm                             Rheumatology or Nephrology




Tuesday, February 15th C2-CC077   Prognostic Factors for Survival in Systemic
1-2pm                             Lupus Erythematosus Associated Pulmonary
                                  Arterial Hypertension


Tuesday, February 15th C2-CC078   Characteristics of Hospitalizations of Patients
1-2pm                             with Systemic Lupus Erythematosus: A
                                  retrospective study from London, Ontario

Tuesday, February 15th C2-CC079   Systemic Lupus Erythematosus Disease
1-2pm                             Activity Index (SLEDAI-2K) Responder Index
                                  (SRI)-50: a Valid Index for Measuring
                                  Improvement in Disease Activity

Tuesday, February 15th C2-CC080   SLEDAI-2K Responder Index (SRI)-50: A
1-2pm                             Reliable Index for Measuring Improvement in
                                  Disease Activity




Tuesday, February 15th C2-CC081   SLEDAI-2K responder index-50 enhances the
1-2pm                             ability to identify responders in clinical trials
Tuesday, February 15th C2-CC082   Comparison of Lupus Quality of Life and SF-
1-2pm                             36 Questionnaires in Lupus Patients with
                                  Moderate Disease Activity-a Cross-sectional
                                  Study




Tuesday, February 15th C2-CC083   Results of a Needs Assessment for Canadian
1-2pm                             Systemic Lupus Erythematosus Guidelines: A
                                  New CANIOS Initiative

Tuesday, February 15th C2-CC084   Prolonged Serologically Active Clinically
1-2pm                             Quiescent (SACQ) Systemic Lupus
                                  Erythematosus (SLE): Novel Predictors of
                                  Flare?




Tuesday, February 15th C2-CC085   Case Based Learning in Pediatric
1-2pm                             Rheumatology - An Effective Method for
                                  Teaching the Medical Expert Role
Tuesday, February 15th C2-CC086   Identifying Patients who are Arthroplasty
1-2pm                             Candidates within a Medically based
                                  Osteoarthritis Education and Treatment
                                  Program

Tuesday, February 15th C2-CC087   A Simulation Model of Medication Use and
1-2pm                             Impact among Persons with Osteoarthritis in
                                  Canada




Tuesday, February 15th C2-CC088   Quality of Life Before and After Joint
1-2pm                             Replacement Surgery


Tuesday, February 15th C2-CC089   Bone Health in Patients with Interstitial Lung
1-2pm                             Disease
Tuesday, February 15th C2-CC090   Optimal Therapy for Osteoporosis in
1-2pm                             Respiratory Patients: A Systematic Review




Tuesday, February 15th C2-CC091   Treating Osteoporosis After A Fragility
1-2pm                             Fracture: The Family Physician As The Hub




Tuesday, February 15th C2-CC092   Arthritis In Celiac Disease Patients Does Not
1-2pm                             Respond Significantly To Gluten Free Diet
                                  Celiac Disease Arthropathy Study– A Single
                                  Centre Canadian Perspective




Tuesday, February 15th C2-CC093   Advanced Clinician Practitioner in Arthritis
1-2pm                             Care (ACPAC) Program-Trained Therapists
                                  in Ontario: Impact on System Integration and
                                  Change




Tuesday, February 15th C2-CC094   Quality Assurance: Pharmacist Feedback on
1-2pm                             a Cost Effective Solution for Rheumatology
                                  Electronic Prescription Software

Tuesday, February 15th C2-CC096   Evaluation of Patient Satisfaction at the
1-2pm                             Sunnybrook Health Sciences Centre
                                  Rheumatology Outpatient Clinic




Tuesday, February 15th C2-CC097   Perceptions of Advanced Clinician
1-2pm                             Practitioner in Arthritis Care (ACPAC)
                                  Program-trained Practitioners: Roles and
                                  Role Utilization within the Ontario Healthcare
                                  System
Tuesday, February 15th C2-CC098   A Systematic Review to Evaluate the Quality
1-2pm                             and Reporting of Administrative Database
                                  Validation Studies for Rheumatic Diseases

Tuesday, February 15th C2-CC099   Community-based Rheumatologists Practice
1-2pm                             Audit during Electronic Medical Record
                                  Implementation


Tuesday, February 15th C2-CC100   Efficacy and Safety of Cannabinoids for Pain
1-2pm                             in Musculoskeletal Diseases: a Systematic
                                  Review and Meta-analysis.




Tuesday, February 15th C2-CC101   An Evaluation of Autoimmune Antibody
1-2pm                             Testing Patterns in a Canadian Health Region
                                  and an Evaluation of a Laboratory Algorithm
                                  Aimed at Reducing Unnecessary Testing




Tuesday, February 15th C2-CC102   Moving From Patient-Centred To Family-
1-2pm                             Centred Care? A Systematic Review Of
                                  Psycho-Educational Programs For People
                                  And Partners Affected By Arthritis

Tuesday, February 15th C2-CC103   Demographics of Seniors Attending a
1-2pm                             Rheumatology Clinic

Tuesday, February 15th C2-CC104   Focus Group to Review a Pilot Education
1-2pm                             Program for Inflammatory Myositis




Tuesday, February 15th C2-CC105   Rheumatology Learning Needs Among
1-2pm                             Physicians in Kenya
Tuesday, February 15th C2-CC106   Risk of developing Myocardial Infarction
1-2pm                             among Uveitis patients.




Tuesday, February 15th C2-CC107   Telemedicine as a Tool Assisting Therapists
1-2pm                             to Deliver Arthritis Care in Remote/Rural
                                  Communities




Tuesday, February 15th C2-CC108   MU2SCLES online: MUsculoskeletal MUlti-
1-2pm                             professional Simulated Collaborative
                                  Learning E-nitiativeS online




Tuesday, February 15th C2-CC109   Effect of Odanacatib on Bone Density and
1-2pm                             Bone Turnover Markers in Postmenopausal
                                  Women with Low Bone Mineral Density: Year
                                  4 Results




Tuesday, February 15th C2-CC110   GAVE Unmasked by Alprostadil for Digital
1-2pm                             Ulceration in a Scleroderma Patient

Tuesday, February 15th C2-CC111   A 50 Year Old Woman with Fever,
1-2pm                             Hemoptysis and Rash


Tuesday, February 15th C2-CC112   Relapsing Polychondritis Associated with
1-2pm                             Hepatitis C Virus Infection


Tuesday, February 15th C2-CC113   Amyloidosis and GCA/PMR: Case Report of a
1-2pm                             Rare Association
Tuesday, February 15th C2-CC114   Multiple Pulmonary Nodules Suspicious for
1-2pm                             Pulmonary Metastases: a Diagnosis
                                  Unmasked by Diffuse Alveolar Hemmorrhage

Tuesday, February 15th C2-CC115   Panniculitis/Fasciitis due to a Drug-Induced
1-2pm                             Neutrophilic Dermatosis: A case report




                         T-01
Sunday, February 13th 1-2pm       Environment and Genetic Contributions
                                  to Disease Severity in First Nations with Early
                                  Inflammatory Arthritis




                         T-03
Sunday, February 13th 1-2pm       Pathogenesis and Prevalence of Anti-
                                  Citrullinated Protein Antibodies (ACPA) in
                                  Unaffected Siblings of ACPA-Positive
                                  Rheumatoid Arthritis Patients



                         T-05
Sunday, February 13th 1-2pm       Validation of the 2010 Criteria to Diagnose
                                  RA in a Canadian Multicenter Cohort Of
                                  Patients with New Onset Inflammatory
                                  Arthritis




                         T-07
Sunday, February 13th 1-2pm       Prevalence of Risk factors for Rheumatoid
                                  Arthritis in a North American Native
                                  Community




                         T-10
Sunday, February 13th 1-2pm       A Population-Based Assessment of Live
                                  Births in Women with SLE
                         T-12
Sunday, February 13th 1-2pm     Prevalence of Flow Mediated Dilatation and
                                its association with Framingham Risk Score
                                in a population of women with Systemic
                                Lupus Erythematosus




                         T-14
Sunday, February 13th 1-2pm     Patterns and Determinants of Leisure-time
                                Physical Activity in Women with Systemic
                                Lupus Erythematosus




                         T-16
Sunday, February 13th 1-2pm     Is There an Advantage for a Lupus Specific
                                Quality of Life Measure over SF-36?



                         T-17
Tuesday, February 15th 1-2pm    Intra-rater reliability of the Bath Ankylosing
                                Spondylitis Disease Activity Index (BASDAI)
                                and the Bath Ankylosing Spondylitis
                                Functional Index (BASFI) in Children with
                                Spondyloarthritis
                         T-19
Tuesday, February 15th 1-2pm    Identification of Anti-TNF Candidates Based
                                on Predicted Response and Remission in
                                Ankylosing Spondylitis




                         T-23
Tuesday, February 15th 1-2pm    Response To The First Biologic In Patients
                                With Ankylosing Spondylitis: A Real World
                                Experience




                         T-26
Sunday, February 13th 1-2pm     Differences in Clinical Manifestations
                                between Childhood-Onset Lupus and Adult-
                                Onset Lupus: A Meta-Analysis

                         T-28
Sunday, February 13th 1-2pm     Health-related Quality of Life in Children with
                                Primary CNS Vasculitis and Juvenile
                                Spondyloarthritis




                         T-30
Sunday, February 13th 1-2pm     Uveitis Screening in Juvenile Idiopathic
                                Arthritis (JIA): A Quality Improvement Project




                         T-32
Sunday, February 13th 1-2pm     Musculoskeletal Examination Skills of
                                Pediatric Residents

                         T-33
Tuesday, February 15th 1-2pm    Cocaine-Induced Pseudovasculitis: a Case
                                Series of 8 Patients
                         T-35
Tuesday, February 15th 1-2pm    Giant Cell Arteritis and Coexisting
                                Inflammatory Arthritis



                         T-37
Tuesday, February 15th 1-2pm    Lower Education as a Proxy for
                                Socioeconomic Status (SES) is not
                                associated with Poor Outcomes in Systemic
                                Sclerosis (SSc): Data from a Large SSc
                                Cohort (CSRG)
                         T-39
Tuesday, February 15th 1-2pm    Clinical Correlates of Oral Health Status in
                                Systemic Sclerosis




                         T-42
Tuesday, February 15th 1-2pm    Joint Space Narrowing has a Stronger Impact
                                on Physical Function Than Joint Erosion:
                                Results From 8-year Longitudinal Analyses




                         T-44
Tuesday, February 15th 1-2pm    Articular Tophus Burden by Dual Energy
                                Computed Tomography and Health-Related
                                Quality of Life




                         T-46
Tuesday, February 15th 1-2pm    Defining the Smallest Detectable Change for
                                the SPARCC Spine and Sacroiliac Joint MRI
                                Index for Ankylosing Spondylitis
                         T-48
Tuesday, February 15th 1-2pm    LMP2 and ERAP1 Variants are Associated
                                With Radiographic Severity in Ankylosing
                                Spondylitis in the SPARCC Cohort
AuthorList
1. Primary Author: Regina M Taylor-Gjevre
2. Additional Author: John A Gjevre
3. Additional Author: Bindu V Nair
4. Additional Author: Robert P Skomro
5. Additional Author: Hyun J Lim


1. Primary Author: M. Genovese
2. Additional Author: A. Cividino
3. Additional Author: E. Keystone
4. Additional Author: F. Breedveld
5. Additional Author: P. Emery
6. Additional Author: S. Cohen
7. Additional Author: E. Matteson
8. Additional Author: L. Burke
9. Additional Author: A. Chai
10. Additional Author: W. Reiss
11. Additional Author: M. Sweetser
12. Additional Author: T. Shaw
1. Primary Author: Ronald van Vollenhoven
2. Additional Author: Alfred Cividino
3. Additional Author: Juan Jose Scali
4. Additional Author: Jeffrey R. Curtis
5. Additional Author: Joel Krasnow
6. Additional Author: Emma Vernon
7. Additional Author: Rieke Alten


1. Primary Author: Bill Bensen
2. Additional Author: Rafat P. Faraawi
3. Additional Author: Hayssam Khalil

1. Primary Author: Bill Bensen
2. Additional Author: Denis Choquette
3. Additional Author: Niall Jones
4. Additional Author: Dalton Sholter
5. Additional Author: Alex Yan
6. Additional Author: Rafat P. Faraawi
7. Additional Author: Heidi Imhoff

1. Primary Author: Bill Bensen
2. Additional Author: Christopher J Atkins
3. Additional Author: Maqbool K Sheriff
4. Additional Author: John T Kelsall
5. Additional Author: Hayssam Khalil
1. Primary Author: Boulos Haraoui
2. Additional Author: Louis Bessette
3. Additional Author: William Bensen
4. Additional Author: Sharon Leclercq
5. Additional Author: Carter Thorne
6. Additional Author: John Wade
7. Additional Author: Eleonora Muratti

1. Primary Author: Boulos Haraoui
2. Additional Author: Maria Bokarewa
3. Additional Author: Vivian Bykerk
4. Additional Author: Ian Kallmeyer

1. Primary Author: Boulos Haraoui
2. Additional Author: Désirée Van der
Heijde
3. Additional Author: Michael H Schiff
4. Additional Author: Edward C Keystone
5. Additional Author: Robert B.M. Landewé
6. Additional Author: Tore K Kvien
7. Additional Author: Jeffrey R Curtis
8. Additional Author: Dinesh Khanna
9. Additional Author: Kristel Luijtens
10. Additional Author: Daniel E Furst



1. Primary Author: Carol A Hitchon
2. Additional Author: Jillian Dooley
3. Additional Author: Gilles Boire
4. Additional Author: Boulos Haraoui
5. Additional Author: Janet Pope
6. Additional Author: Carter Thorne
7. Additional Author: Diane Ferland
8. Additional Author: Vivian P Bykerk
9. Additional Author: Network of Early
Arthritis Researchers

1. Additional Author: Carter Thorne
2. Additional Author: Alfred Cividino
3. Additional Author: Janet Pope
4. Additional Author: Sasha Bernatsky
5. Additional Author: Xiuying Li
6. Additional Author: Huda Ashoor
7. Additional Author: Angela Cesta
8. Primary Author: Claire Bombardier

1. Primary Author: Carter Thorne
2. Additional Author: Bill Bensen
3. Additional Author: Susan M Otawa
1. Primary Author: Cheryl Barnabe
2. Additional Author: Louis Bessette
3. Additional Author: Cathy Flanagan
4. Additional Author: Sharon Leclercq
5. Additional Author: Vivian P Bykerk

1. Primary Author: Cheryl Barnabe
2. Additional Author: Janet Pope
3. Additional Author: Gilles Boire
4. Additional Author: Carol A Hitchon
5. Additional Author: Boulos Haraoui
6. Additional Author: Carter Thorne
7. Additional Author: Edward C Keystone
8. Additional Author: Diane Ferland
9. Additional Author: Vivian P Bykerk


1. Primary Author: Claire Bombardier
2. Additional Author: Nathan Bradshaw
3. Additional Author: Angela Cesta
4. Additional Author: Annette Wilkins
5. Additional Author: Jack An
6. Additional Author: Edward C Keystone
7. Additional Author: Ron Heslegrave


1. Primary Author: David Rowe
2. Additional Author: Carter Thorne
3. Additional Author: CATCH Scientific
Advisory Committee

1. Primary Author: Denis Choquette
2. Additional Author: Bill Bensen
3. Additional Author: Milton F Baker
4. Additional Author: Hayssam Khalil

1. Additional Author: Irene A Smolik
2. Additional Author: David B Robinson
3. Additional Author: Quir Tan
4. Additional Author: Donna Hart
5. Additional Author: Marianna M Newkirk
6. Additional Author: Charles N Bernstein
7. Additional Author: Xikui Wang
8. Primary Author: Hani El-Gabalawy
1. Primary Author: Josef S Smolen
2. Additional Author: Ronald Van
Vollenhoven
3. Additional Author: Arthur Kavanaugh
4. Additional Author: Andreas Fichtner
5. Additional Author: Vibeke Strand
6. Additional Author: Jiri Vencovsky
7. Additional Author: Désirée Van der
Heijde

1. Primary Author: Josef S Smolen
2. Additional Author: Ronald Van
Vollenhoven
3. Additional Author: Arthur Kavanaugh
4. Additional Author: Kristel Luijtens
5. Additional Author: Désirée Van der
Heijde
6. Additional Author: Jeffrey R Curtis

1. Primary Author: Vibeke Strand
2. Additional Author: Ronald Van
Vollenhoven
3. Additional Author: Tore K Kvien
4. Additional Author: Bernard Combe
5. Additional Author: Dinesh Khanna
6. Additional Author: Gerd R Burmester
7. Additional Author: E. Nikai
8. Additional Author: G. Coteur
9. Additional Author: Josef S Smolen
10. Additional Author: Michael H Schiff

1. Primary Author: Ronald van Vollenhoven
2. Additional Author: Kenneth Blocka
3. Additional Author: P. Emery
4. Additional Author: Clifton O Bingham
5. Additional Author: E. Keystone
6. Additional Author: Roy M. Fleischmann
7. Additional Author: Daniel E. Furst
8. Additional Author: Katherine Macey
9. Additional Author: Marianne Sweetser
10. Additional Author: Patricia Lehane
11. Additional Author: Pam Farmer
12. Additional Author: Simon G. Long




1. Primary Author: Lorna Bain
2. Additional Author: Janice Mulligan
3. Additional Author: Sandra Mierdel
4. Additional Author: Carter Thorne
1. Primary Author: Paul Davis
2. Additional Author: Angela G Juby

1. Primary Author: Majed Khraishi
2. Additional Author: Boulos Haraoui
3. Additional Author: Rieke Alten
4. Additional Author: Juan J. Gomez-Reino
5. Additional Author: Warren Rizzo
6. Additional Author: Joy Schechtman
7. Additional Author: Andre Kahan
8. Additional Author: Emma Vernon
9. Additional Author: Monet Taylor
10. Additional Author: Joseph S. Smolen



1. Primary Author: Charmaine Navis
2. Additional Author: Paul Davis
3. Additional Author: Walter P.
Maksymowych
4. Additional Author: Elaine Ann Yacyshyn


1. Primary Author: Pooneh Akhavan
2. Additional Author: Maggie Chen
3. Additional Author: Xiuying Li
4. Additional Author: Claire Bombardier

1. Primary Author: Graeme Jones
2. Additional Author: Rafat Faraawi
3. Additional Author: Anthony Sebba
4. Additional Author: Guillermo Tate
5. Additional Author: Andre Beaulieu
6. Additional Author: Emma Vernon
7. Additional Author: M. Genovese

1. Primary Author: Rafat Faraawi
2. Additional Author: Kelly Roth

1. Primary Author: Rafat P. Faraawi
2. Additional Author: Susan M Otawa



1. Primary Author: Ranjani Somayaji
2. Additional Author: Cheryl Barnabe
3. Additional Author: Liam Martin
1. Primary Author: Regina M Taylor-Gjevre
2. Additional Author: John A Gjevre
3. Additional Author: Bindu V Nair
4. Additional Author: Robert P Skomro
5. Additional Author: Hyun J Lim


1. Primary Author: Tristan Boyd
2. Additional Author: Vivian P Bykerk
3. Additional Author: Boulos Haraoui
4. Additional Author: Carter Thorne
5. Additional Author: Carol A Hitchon
6. Additional Author: Gilles Boire
7. Additional Author: Janet Pope

1. Primary Author: P. Emery
2. Additional Author: W. P. Olszynski
3. Additional Author: P. J. Mease
4. Additional Author: A. Rubbert-Roth
5. Additional Author: J. R. Curtis
6. Additional Author: U. Müller-Ladner
7. Additional Author: N. Gaylis
8. Additional Author: S. Williams
9. Additional Author: H. Tyrell
10. Additional Author: M. Reynard

1. Additional Author: Brigitta Choi
2. Additional Author: Ines Colmegna
3. Primary Author: Susan J Bartlett

1. Primary Author: John Kelsall
2. Additional Author: Mary De Vera
3. Additional Author: Pamela Rogers
4. Additional Author: Griselda Galindo
5. Additional Author: Alice Klinkhoff

1. Primary Author: John Kelsall
2. Additional Author: Mary De Vera
3. Additional Author: Pamela Rogers
4. Additional Author: Griselda Galindo
5. Additional Author: Alice Klinkhoff

1. Primary Author: Kelly Warmington
2. Additional Author: Carol A Kennedy
3. Additional Author: Dorcas Beaton
4. Additional Author: Rachel Shupak
5. Additional Author: Sheilah Hogg-Johnson
12. Additional Author: Simon G. Long
1. Primary Author: Lina Wang
2. Additional Author: Robin Roots
3. Additional Author: Pamela Rogers
4. Additional Author: Diane Lacaille

1. Additional Author: Jennifer Ringrose
2. Primary Author: Regina M Taylor-Gjevre
3. Additional Author: Stephen Sanche
4. Additional Author: Vernon Hoeppner


1. Primary Author: Jacob Karsh
2. Additional Author: Lyn S. Maguire
3. Additional Author: Canadian
Rheumatology Research Consortium (CRRC)


1. Primary Author: Robert B.M. Landewé
2. Additional Author: Edward C Keystone
3. Additional Author: Josef S Smolen
4. Additional Author: Mary Goldring
5. Additional Author: Benoît Guérette
6. Additional Author: Kaushik Patra
7. Additional Author: Mary Cifaldi
8. Additional Author: Désirée Van der
Heijde



1. Primary Author: Edward C Keystone
2. Additional Author: Michael E. Weinblatt
3. Additional Author: Boulos Haraoui
4. Additional Author: Benoît Guérette
5. Additional Author: Neelufar Mozaffarian
6. Additional Author: Kaushik Patra
7. Additional Author: Arthur Kavanaugh



1. Primary Author: Mary J Bell
2. Additional Author: Ruben Tavares
3. Additional Author: Joel Scarf
1. Primary Author: Jessica Widdifield
2. Additional Author: Sasha Bernatsky
3. Additional Author: Michael Paterson
4. Additional Author: Nadia Gunraj
5. Additional Author: Carter Thorne
6. Additional Author: Janet Pope
7. Additional Author: Alfred Cividino
8. Additional Author: Claire Bombardier

1. Primary Author: Jessica Widdifield
2. Additional Author: Sasha Bernatsky
3. Additional Author: Michael Paterson
4. Additional Author: Nadia Gunraj
5. Additional Author: Carter Thorne
6. Additional Author: Janet Pope
7. Additional Author: Alfred Cividino
8. Additional Author: Claire Bombardier

1. Primary Author: Walter P Maksymowych
2. Additional Author: Arto Ensio Ohinmaa
3. Additional Author: Liam Martin
4. Additional Author: Anthony S Russell
5. Additional Author: Susan Barr
6. Additional Author: Dalton Sholter
7. Additional Author: Christopher Penney
8. Additional Author: Yan Charles
9. Additional Author: Phil Jacobs




1. Primary Author: Michael Zawadowski
2. Additional Author: Regina M Taylor-
Gjevre

1. Primary Author: Jai Jayakar
2. Additional Author: Lihi Eder
3. Additional Author: Arane Thavaneswaran
4. Additional Author: Sutha Shanmugarajah
5. Additional Author: Dafna D. Gladman



1. Primary Author: Dafna D. Gladman
2. Additional Author: Vinod Chandran
3. Additional Author: Arane Thavaneswaran
4. Additional Author: Michel Zummer
1. Primary Author: Gina Hamilton
2. Additional Author: Yvonne Tobin
3. Additional Author: Rose Ardern
4. Additional Author: Proton Rahman

1. Primary Author: Zahi Touma
2. Additional Author: Lihi Eder
3. Additional Author: Devy Zisman
4. Additional Author: Joy Feld
5. Additional Author: Vinod Chandran
6. Additional Author: Cheryl Rosen
7. Additional Author: Hua Shen
8. Additional Author: Richard Cook
9. Additional Author: Dafna D. Gladman

1. Primary Author: Elaine Dupuis
2. Additional Author: Jan P Dutz

1. Primary Author: Walter P. Maksymowych
2. Additional Author: Désirée Van der
Heijde
3. Additional Author: Robert Landewé
4. Additional Author: Aileen Pangan
5. Additional Author: L. Steve Brown
6. Additional Author: Frederic Lavie


1. Primary Author: Cheryl Barnabe
2. Additional Author: Lawrence Joseph
3. Additional Author: Steven Edworthy
4. Additional Author: Patrick Belisle
5. Additional Author: Larry Svenson
6. Additional Author: Jeremy Labrecque
7. Additional Author: Brenda Hemmelgarn
8. Additional Author: Susan Barr
9. Additional Author: Sasha Bernatsky


1. Primary Author: Ilya Razykov
2. Additional Author: Marie Hudson
3. Additional Author: Murray Baron
4. Additional Author: Brett D. Thombs

1. Primary Author: Kyle Walker
2. Additional Author: Janet Pope

1. Primary Author: Kyle Walker
2. Additional Author: The CSRG and SCTC
3. Additional Author: Janet Pope
1. Primary Author: Sabrina Gravel
2. Additional Author: Murray Baron
3. Additional Author: Marie Hudson
4. Additional Author: Ernest Lo
5. Additional Author: Geneviève Gyger
6. Additional Author: Canadian Scleroderma
Research Group (CSRG)
7. Additional Author: Mervyn Gornitsky

1. Additional Author: Steven J Katz
2. Additional Author: Alex Yan
3. Primary Author: Muneeb Ilyas

1. Primary Author: Genevieve Gyger
2. Additional Author: Marie Hudson
3. Additional Author: Ernest Lo
4. Additional Author: Sabrina Gravel
5. Additional Author: Mervyn Gornitsky
6. Additional Author: Murray Baron

1. Primary Author: Amanda Steiman
2. Additional Author: Vivian Bykerk
3. Additional Author: Heather Thiessen-
Philbrook
4. Additional Author: Lihua Li
5. Additional Author: Dianne Mosher
6. Additional Author: Cathy Flanagan
7. Additional Author: Boulos Haraoui
8. Additional Author: Louis Bessette
9. Additional Author: Sharon Leclercq
10. Additional Author: Carter Thorne
11. Additional Author: Janet Pope
1. Primary Author: Saima Chohan
2. Additional Author: Michael Becker
3. Additional Author: Patricia MacDonald
4. Additional Author: Robert Palmer
5. Additional Author: Solomon Chefo
6. Additional Author: Robert Jackson


1. Primary Author: Maggie Chen
2. Additional Author: Xiuying Li
3. Additional Author: Pooneh Akhavan
4. Additional Author: Claire Bombardier
1. Primary Author: Susan Humphrey-Murto
2. Additional Author: Michelle Cicalo
3. Additional Author: Gina Diprimio
4. Additional Author: Nataliya Milman
5. Additional Author: Adnan Sheikh
6. Additional Author: Stephanie Sutherland



1. Primary Author: Eric C Sayre
2. Additional Author: Joel Singer
3. Additional Author: Anona Thorne
4. Additional Author: Hubert Wong
5. Additional Author: Jacek Kopec
6. Additional Author: John M Esdaile
7. Additional Author: Ali Guermazi
8. Additional Author: Savvas Nicolaou
9. Additional Author: Jolanda Cibere

1. Primary Author: Michelle Teo
2. Additional Author: Stephanie O Keeling


1. Primary Author: Cheryl Barnabe
2. Additional Author: Lawrence Joseph
3. Additional Author: Steven Edworthy
4. Additional Author: Patrick Belisle
5. Additional Author: Larry Svenson
6. Additional Author: Jeremy Labrecque
7. Additional Author: Brenda Hemmelgarn
8. Additional Author: Susan Barr
9. Additional Author: Sasha Bernatsky


1. Primary Author: Cheryl Barnabe
2. Additional Author: Peter Faris
3. Additional Author: Hude Quan

1. Primary Author: Ellie Aghdassi
2. Additional Author: Paul R. Fortin
3. Additional Author: Stacey Morrison
4. Additional Author: Jiandong Su
5. Additional Author: Carolyn Neville
6. Additional Author: Sara Hewitt
7. Additional Author: Janet Pope
8. Additional Author: Deborah Da Costa
1. Primary Author: Hang Shi
2. Additional Author: Nicole Anderson
3. Additional Author: Dominique Ibanez
4. Additional Author: Dafna D. Gladman
5. Additional Author: Murray Urowitz

1. Primary Author: Elizabeth Pek
2. Additional Author: Dafna D. Gladman
3. Additional Author: Dominique Ibanez
4. Additional Author: Murray Urowitz

1. Primary Author: Mai Nguyen
2. Additional Author: John R McVagh
3. Additional Author: Janet Pope
4. Additional Author: Earl D. Silverman
5. Additional Author: Paul R. Fortin
6. Additional Author: C. Douglas Smith
7. Additional Author: Carol A Hitchon
8. Additional Author: Michel Zummer
9. Additional Author: Marie Hudson
10. Additional Author: Sasha Bernatsky
11. Additional Author: Ann E Clarke
12. Additional Author: Christian A Pineau
13. Additional Author: Murray Urowitz
14. Additional Author: Dafna D. Gladman
15. Additional Author: 14. Additional Author:
Hector Arbillaga
16. Additional Author: Lori Tucker
17. Additional Author: CaNIOS Investigators
18. Additional Author: Christine A Peschken




1. Primary Author: Claire Barber
2. Additional Author: Andrew Herzenberg
3. Additional Author: Ellie Aghdassi
4. Additional Author: Jiandong Su
5. Additional Author: Wendy Lou
6. Additional Author: Gan Qian
7. Additional Author: Jonathan Yip
8. Additional Author: Samih Nasr
9. Additional Author: David Thomas
10. Additional Author: Joan Wither
11. Additional Author: Murray Urowitz
12. Additional Author: Dafna D. Gladman
13. Additional Author: Heather N Reich
14. Additional Author: Paul R. Fortin
1. Primary Author: Serena Cheung
2. Additional Author: Erik Beuker
3. Additional Author: Steven J Katz
4. Additional Author: Neesh Pannu
5. Additional Author: Dwight Harley
6. Additional Author: Elaine Ann Yacyshyn


1. Primary Author: Shirley L Chow
2. Additional Author: Vinod Chandran
3. Additional Author: Rouhi Fazelzad
4. Additional Author: Sindhu R Johnson

1. Primary Author: June Lee
2. Additional Author: Janet Pope


1. Primary Author: Zahi Touma
2. Additional Author: Dafna D. Gladman
3. Additional Author: Dominique Ibanez
4. Additional Author: Murray Urowitz

1. Primary Author: Zahi Touma
2. Additional Author: Murray Urowitz
3. Additional Author: Paul R. Fortin
4. Additional Author: Carolina Landolt-
Marticorena
5. Additional Author: Sergio M Toloza
6. Additional Author: Claire Riddell
7. Additional Author: Vinod Chandran
8. Additional Author: Lihi Eder
9. Additional Author: Aqeel Ghanem
10. Additional Author: Olga Ziouzina
11. Additional Author: Shahrzad Taghavi-
zadeh
12. Additional Author: Dominique Ibanez
13. Additional Author: Dafna D. Gladman



1. Primary Author: Zahi Touma
2. Additional Author: Dafna D. Gladman
3. Additional Author: Dominique Ibanez
4. Additional Author: Shahrzad Taghavi-
zadeh
5. Additional Author: Murray Urowitz
1. Primary Author: Zahi Touma
2. Additional Author: Murray Urowitz
3. Additional Author: Dominique Ibanez
4. Additional Author: Shahrzad Taghavi-
zadeh
5. Additional Author: Dafna D. Gladman

1. Primary Author: Stephanie O Keeling



1. Primary Author: Amanda Steiman
2. Additional Author: Murray Urowitz
3. Additional Author: Joan Wither
4. Additional Author: Dominique Ibanez
5. Additional Author: Timothy Li
6. Additional Author: Dafna D. Gladman

1. Primary Author: Roman Jurencak
2. Additional Author: Johannes Roth

1. Primary Author: Lorna J. Bain
2. Additional Author: Lisa Denning
3. Additional Author: Sandra Mierdel
4. Additional Author: Carter Thorne

1. Primary Author: Jacek A Kopec
2. Additional Author: Eric C Sayre
3. Additional Author: M Mushfiqur Rahman
4. Additional Author: Weiqun Kang
5. Additional Author: Philippe Finès
6. Additional Author: William M Flanagan
7. Additional Author: Jolanda Cibere
8. Additional Author: Nicholas J Bansback
9. Additional Author: Aslam H Anis
10. Additional Author: Elizabeth M Badley




1. Primary Author: Jacek A Kopec
2. Additional Author: M Mushfiqur Rahman


1. Primary Author: Ganesh Subramanian
2. Additional Author: Tripti Papneja
3. Additional Author: Elaine Ann Yacyshyn
1. Primary Author: Ganesh Subramanian
2. Additional Author: Tripti Papneja
3. Additional Author: Elaine Ann Yacyshyn



1. Primary Author: Marie-Claude Beaulieu
2. Additional Author: Suzanne Gosselin
3. Additional Author: Isabelle Gaboury
4. Additional Author: Alain Vanasse
5. Additional Author: François Cabana
6. Additional Author: Gilles Boire


1. Primary Author: Tariq Iqbal
2. Additional Author: MUKARRAM ALI
ZAIDI
3. Additional Author: GEORGE A WELLS
4. Additional Author: JACOB KARSH


1. Primary Author: Carol A Kennedy
2. Additional Author: Kelly Warmington
3. Additional Author: Leslie Soever
4. Additional Author: Laura A Passalent
5. Additional Author: Sydney Lineker
6. Additional Author: Ryan Thomas
7. Additional Author: Katie Lundon
8. Additional Author: Rachel Shupak
9. Additional Author: Rayfel Schneider

1. Primary Author: Steven J Katz
2. Additional Author: Elaine Ann Yacyshyn


1. Primary Author: Jenny Shu
2. Additional Author: Paula Veinot
3. Additional Author: Ruben Tavares
4. Additional Author: Jennifer Boyle
5. Additional Author: Mary J Bell

1. Primary Author: Kelly Warmington
2. Additional Author: Carol A Kennedy
3. Additional Author: Katie Lundon
4. Additional Author: Linda Rozmovits
5. Additional Author: Sydney Lineker
6. Additional Author: Rachel Shupak
7. Additional Author: Rayfel Schneider
1. Primary Author: Jessica Widdifield
2. Additional Author: Jeremy Labrecque
3. Additional Author: Lisa Lix

1. Primary Author: Manoji Pereira
2. Additional Author: Matthew Got
3. Additional Author: Andrew Chow
4. Additional Author: Elaine Soucy

1. Primary Author: Tabitha N. Kung
2. Additional Author: Jacqueline R.
Hochman
3. Additional Author: Ye Sun
4. Additional Author: Louis Bessette
5. Additional Author: Boulos Haraoui
6. Additional Author: Janet Pope
7. Additional Author: Vivian P Bykerk

1. Primary Author: Ada W Man
2. Additional Author: Kam Shojania
3. Additional Author: Carmen Phoon
4. Additional Author: Jason Pal
5. Additional Author: Monika Hudoba de
Badyn
6. Additional Author: Pi David
7. Additional Author: Diane Lacaille

1. Primary Author: Allen J Lehman
2. Additional Author: Sennait Yohannes
3. Additional Author: Cynthia M MacDonald


1. Primary Author: Paul Davis
2. Additional Author: Angela G Juby

1. Primary Author: Anita Dey
2. Additional Author: Lois Flakstad
3. Additional Author: Kathy Cotton
4. Additional Author: Stephanie Oksana
Keeling

1. Primary Author: Ines Colmegna
2. Additional Author: Susan J Bartlett
3. Additional Author: Omondi G Oyoo
1. Primary Author: Michelle Leger
2. Additional Author: M Mushfiqur Rahman
3. Additional Author: Jaafar Aghajanian
4. Additional Author: Kevin Wade
5. Additional Author: Hyon Choi
6. Additional Author: Kam Shojania


1. Primary Author: Sydney Lineker
2. Additional Author: Mary Ellen Marcon
3. Additional Author: Jocelyne Murdock
4. Additional Author: Sue MacQueen
5. Additional Author: Diane McGall
6. Additional Author: Barbara Brown
7. Additional Author: Julie Herrington

1. Primary Author: Jodie Jeffery
2. Additional Author: Regina M Taylor-
Gjevre
3. Additional Author: Liz Harrison
4. Additional Author: Anne Dzus
5. Additional Author: Rob Woods
6. Additional Author: Jordan Buchko
7. Additional Author: Katie Rooks
8. Additional Author: Michael Katz
9. Additional Author: Sathish Rajasekaran


1. Primary Author: Albert Leung
2. Additional Author: Romana Petrovic
3. Additional Author: Carolyn DaSilva
4. Additional Author: Elizabeth Rosenberg
5. Additional Author: Arthur Santora
6. Additional Author: Antonio Lombardi


1. Primary Author: Mohammed A Omair
2. Additional Author: Sindhu R Johnson

1. Primary Author: Zorheh Sabbagh
2. Additional Author: Regina M Taylor-
Gjevre

1. Primary Author: Iman Hemmati
2. Additional Author: Eric M Yoshida
3. Additional Author: Kam Shojania

1. Primary Author: Kimberly Legault
2. Additional Author: Anjali Shroff
3. Additional Author: Mark Crowther
4. Additional Author: Nader Khalidi
1. Primary Author: Jodie Jeffery
2. Additional Author: Chris Hergott
3. Additional Author: John A Gjevre

1. Primary Author: Nathaniel Dostrovsky
2. Additional Author: Srinivasan . Harish
3. Additional Author: Madeleine Verhovsek
4. Additional Author: Samih Salama
5. Additional Author: Nader Khalidi


1. Additional Author: Trevor Mailey
2. Additional Author: Jillian Dooley
3. Additional Author: Christine A Peschken
4. Additional Author: Peter Nickerson
5. Primary Author: Carol A Hitchon


1. Primary Author: Lillian Barra
2. Additional Author: Mathias Scinocca
3. Additional Author: Elizabeth Wilson
4. Additional Author: Kelly Summers
5. Additional Author: Ewa Cairns
6. Additional Author: David Bell

1. Primary Author: Vivian Bykerk
2. Additional Author: Boulos Haraoui
3. Additional Author: Gilles Boire
4. Additional Author: Carol A Hitchon
5. Additional Author: Edward C Keystone
6. Additional Author: Carter Thorne
7. Additional Author: Diane Ferland
8. Additional Author: Janet Pope
9. Additional Author: CATCH Investigators
of Canada


1. Additional Author: Isanne Schacter
2. Additional Author: Fatiha Chandad
3. Additional Author: Irene A Smolik
4. Additional Author: David B Robinson
5. Additional Author: Donna Hart
6. Primary Author: Hani El-Gabalawy

1. Primary Author: Evelyne Vinet
2. Additional Author: Jeremy Labrecque
3. Additional Author: Yvan St-Pierre
4. Additional Author: Christian A Pineau
5. Additional Author: Ann E Clarke
6. Additional Author: Sasha Bernatsky
1. Primary Author: Valentina Peeva
2. Additional Author: Paula Harvey
3. Additional Author: Jiandong Su
4. Additional Author: Ellie Aghdassi
5. Additional Author: Ali Al-Dhanhani
6. Additional Author: Stacey Morrison
7. Additional Author: Christian A Pineau
8. Additional Author: Janet Pope
9. Additional Author: Deborah Da Costa
10. Additional Author: Paul R. Fortin

1. Primary Author: ZiLi Wang
2. Additional Author: Deborah Da Costa
3. Additional Author: Ellie Aghdassi
4. Additional Author: Jiandong Su
5. Additional Author: Janet Pope
6. Additional Author: Christian A Pineau
7. Additional Author: Paul R. Fortin

1. Primary Author: Zahi Touma
2. Additional Author: Dafna D. Gladman
3. Additional Author: Dominique Ibanez
4. Additional Author: Murray Urowitz

1. Primary Author: Bertha Wong
2. Additional Author: Michelle Batthish
3. Additional Author: Alisa Rachlis
4. Additional Author: Samantha Stephens
5. Additional Author: Michelle Anderson
6. Additional Author: Brian M. Feldman
7. Additional Author: Ronald M Laxer
8. Additional Author: Joanne Marcuz
9. Additional Author: Margaret Reaume
10. Additional Author: Lynn R. Spiegel
11. Additional Author: Kristi Whitney
12. Additional Author: Shirley Tse
1. Additional Author: Nathan Vastesaeger
2. Additional Author: Désirée Van der
Heijde
3. Primary Author: Robert D. Inman
4. Additional Author: Yanxin Wang
5. Additional Author: Atul Deodhar
6. Additional Author: Benjamin Hsu
7. Additional Author: Mahboob Rahman
8. Additional Author: Ben A.C. Dijkmans
9. Additional Author: Piet Geusens
10. Additional Author: Joachim Seiper
11. Additional Author: Jürgen Braun



1. Primary Author: Nigil Haroon
2. Additional Author: Adele Carty
3. Additional Author: Nai Lee Lui
4. Additional Author: Hua Shen
5. Additional Author: Richard Cook
6. Additional Author: Robert Inman

1. Primary Author: Brieanna Livingston
2. Additional Author: Ashley Bonner
3. Additional Author: Janet Pope

1. Primary Author: Jennifer Sy
2. Additional Author: Susanne M. Benseler
3. Additional Author: Shehla Sheikh
4. Additional Author: Kristi Whitney
5. Additional Author: Joanne Marcuz
6. Additional Author: Michelle Anderson
7. Additional Author: Holly Convery
8. Additional Author: Shirley Tse


1. Primary Author: Meghan Ho
2. Additional Author: Shirley Tse
3. Additional Author: Traudel Saurenmann
4. Additional Author: Shehla Sheikh
5. Additional Author: Melitta Wasylciw
6. Additional Author: Susanne M. Benseler



1. Primary Author: Roman Jurencak
2. Additional Author: Johannes Roth

1. Primary Author: Nataliya Milman
2. Additional Author: C. Douglas Smith
1. Primary Author: William Leung
2. Additional Author: Todd Chaba
3. Additional Author: Elaine Ann Yacyshyn


1. Primary Author: Samah Mansour
2. Additional Author: Ashley Bonner
3. Additional Author: Murray Baron
4. Additional Author: Janet Pope

1. Primary Author: Genevieve Gyger
2. Additional Author: Marie Hudson
3. Additional Author: Ernest Lo
4. Additional Author: Sabrina Gravel
5. Additional Author: Mervyn Gornitsky
6. Additional Author: Murray Baron

1. Primary Author: Désirée Van der Heijde
2. Additional Author: Robert B.M. Landewé
3. Additional Author: Benoît Guérette
4. Additional Author: Sanjoy Roy
5. Additional Author: Kaushik Patra
6. Additional Author: Edward C Keystone




1. Primary Author: Caroline A MacCallum
2. Additional Author: Lindsay Wall-Burns
3. Additional Author: Vidula Bhole
4. Additional Author: Mary De Vera
5. Additional Author: Savvas Nicolaou
6. Additional Author: Kam Shojania
7. Additional Author: Graham Reid
8. Additional Author: A Eftekhari
9. Additional Author: Mohammed
Abufayyah
10. Additional Author: Genevieve Law
11. Additional Author: Hyon Choi



1. Primary Author: Walter P. Maksymowych
2. Additional Author: Robert Gw Lambert
3. Additional Author: Kaushik Patra
4. Additional Author: Aileen Pangan
1. Primary Author: Nigil Haroon
2. Additional Author: Walter P
Maksymowych
3. Additional Author: Proton Rahman
4. Additional Author: Florence Tsui
5. Additional Author: Robert Inman

								
To top